BWAY
BrainswayBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Primary company releases support real operating momentum: 2025 revenue grew 27% to $52.2 million, profitability improved, 2026 guidance was raised into another 27%-30% growth year, and management is stacking regulatory, reimbursement, and strategic-network initiatives behind the platform [#PR-2026-03-11].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -11.9.
What can break
Execution miss versus 2026 guidance after a strong Q4/FY2025 setup
Momentum
78
Value
57
Sentiment
40
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $13.00 · Bull $18.00 · Bear $10.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-05-29 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $13.17
Why
Momentum78 · Δ7d -11.9
Value57 · Δ7d +0.1
Sentiment40 · Δ7d +0.8
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
78
34% active weight
Current posture
7d trendSoftening
Δ7d
-11.9
Δ21d
-19.3
Value
57
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.5
Sentiment
40
33% active weight
Current posture
7d trendFlat
Δ7d
+0.8
Δ21d
+13.7
Why this grade
Composite grade B. Momentum 78.0 / Value 57.4 / Sentiment 39.5
Fundamentals (TTM)As of 2026-05-29
Fundamentals (TTM)
As of 2026-05-29
Market Cap
$662.38M
Beta
1.40
Shares Out
39.16M
P/E (TTM)
67.3
P/S (TTM)
8.04
P/FCF (TTM)
21.51
Rev YoY
+28.7%
EPS YoY
+101.5%
Gross Margin
+74.9%
Op Margin
+5.8%
Net Debt
-$63.72M
Current Ratio
3.19
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology